EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieKohortenstudieOpen Access · CC BY 4.0

Angioedema Due to Acquired C1-Inhibitor Deficiency Without Hematological Condition: A Multicenter French Cohort Study of 34 Patients

Romain Stammler, Federica Defendi, Magali Aubineau, Beatrice Bibes, Isabelle Boccon-Gibod, Laurence Bouillet, Yoann Crabol, Marie Caroline Dalmas, Claire de Moreuil, Aurelien Delluc, Claire Dingremont, Aurelie Du-Thanh und 10 weitere

The Journal of Allergy and Clinical Immunology: In Practice · 2025

DOI: 10.1016/j.jaip.2024.12.027 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2025. Verfasst von Romain Stammler und 21 weiteren Autor:innen. Beteiligte Einrichtung: Service de Médecine Interne, Hôpital Saint Antoine, AP-HP, Sorbonne Université, Paris, France. Hauptthemen laut MEDLINE: Angioedema, Complement C1 Inhibitor Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Angioedema (AE) due to acquired C1-inhibitor deficiency (AAE-C1-INH) is a rare disease associating recurrent edema of the mucosa and skin. Several underlying diseases have been reported, mainly lymphoproliferative diseases and monoclonal gammopathy. However, 15% to 20% of patients never exhibit such a hematological condition. OBJECTIVE: To analyze specific features of patients with AAE-C1-INH without a hematological condition. METHODS: This is a multicenter, retrospective cohort study of patients with AAE-C1-INH without a hematological condition included from January 1999 to May 2024 in the French national CREAK (Centre de reference des angioedèmes à kinine) registry. The clinical and biological characteristics of patients were detailed and then compared with those of patients with AAE-C1-INH associated with lymphoid hemopathies or monoclonal gammopathy. RESULTS: Thirty-four patients were included. All patients displayed a functional C1-INH below 50% of the reference value, 26 (76%) also had a decreased C1-INH antigen level, and 26 (76%) displayed anti-C1-INH antibodies. After a median follow-up of 65 months, 4 (12%) patients were in spontaneous complete remission of AE; 15 (44%) were in complete response under long-term prophylactic treatment. Compared with 75 patients with lymphoma-associated AAE-C1-INH, patients with AAE-C1-INH without a hematological condition displayed a higher incidence of anti-C1-INH antibodies and received more frequently symptomatic or prophylactic treatment with a lower remission rate at last follow-up. Clinical and biological features of patients with AAE-C1-INH without a hematological condition were similar to those of 30 patients with monoclonal gammopathy-associated AAE-C1-INH. CONCLUSIONS: AAE-C1-INH without a hematological condition displays a different clinical and biological presentation from lymphoma-associated AAE-C1-INH. No autoimmune disease was identified. Unlike rituximab, long-term prophylaxis seems to prevent AE attacks among these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AngioedemaComplement C1 Inhibitor ProteinAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedCohort StudiesFranceParaproteinemiasRetrospective Studies

Stichwörter der Autor:innen

Acquired angioedemaAngioedemaAutoimmune diseasesParaneoplastic syndrome

Substanzen

Complement C1 Inhibitor Protein

Autor:innen und Institutionen

  • Service de Médecine Interne, Hôpital Saint Antoine, AP-HP, Sorbonne Université, Paris, France.
  • Immunology Department, Grenoble University Hospital, Grenoble, France.
  • Internal Medicine Department, Hospices Civils de Lyon, Lyons, France.
  • Internal Medicine Department, Saint Grégoire Hospital, Rennes, France.
  • French National Reference Center for Angioedema (CREAK), Internal Medicine Department, Grenoble University Hospital, Grenoble, France.
  • Internal Medicine Department, Vanne-Auray Hospital Center, Vanne, France.

Zitieren

APA

Stammler, R., Defendi, F., Aubineau, M., Bibes, B., Boccon-Gibod, I., Bouillet, L., Crabol, Y., Dalmas, M. C., de Moreuil, C., Delluc, A., Dingremont, C., Du-Thanh, A., Hadjadj, J., Jeandel, P. Y., Kalmi, G., Lacoste, M., Martin, L., Avoy, C. M., Blanchard-Delaunay, C., …, & Gobert, D. (2025). Angioedema Due to Acquired C1-Inhibitor Deficiency Without Hematological Condition: A Multicenter French Cohort Study of 34 Patients. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2024.12.027

Vancouver

Stammler R, Defendi F, Aubineau M, Bibes B, Boccon-Gibod I, Bouillet L, et al. Angioedema Due to Acquired C1-Inhibitor Deficiency Without Hematological Condition: A Multicenter French Cohort Study of 34 Patients. The Journal of Allergy and Clinical Immunology: In Practice. 2025. doi:10.1016/j.jaip.2024.12.027

BibTeX
@article{Stammler2025,
  author = {Stammler, Romain and Defendi, Federica and Aubineau, Magali and Bibes, Beatrice and Boccon-Gibod, Isabelle and Bouillet, Laurence and Crabol, Yoann and Dalmas, Marie Caroline and de Moreuil, Claire and Delluc, Aurelien and Dingremont, Claire and Du-Thanh, Aurelie and Hadjadj, Jerome and Jeandel, Pierre-Yves and Kalmi, Galith and Lacoste, Marion and Martin, Ludovic and Avoy, Chloé Mc and Blanchard-Delaunay, Claire and Taquet, Marie Caroline and Fain, Olivier and Gobert, Delphine},
  title = {Angioedema Due to Acquired C1-Inhibitor Deficiency Without Hematological Condition: A Multicenter French Cohort Study of 34 Patients},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2025},
  doi = {10.1016/j.jaip.2024.12.027}
}
Kostenlos starten →